Drug and device manufacturers provide more than half the funding for continuing medical education (CME) and indirectly influence its content. The authors describe potential strategies to safeguard CME from bias and to improve its value to clinicians.
No takes yet. Share an insight, caveat, or question.
Morris et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: